225 related articles for article (PubMed ID: 15071740)
1. Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats.
Barone M; Maiorano E; Ladisa R; Pece A; Berloco P; Strazzabosco M; Caruso ML; Valentini AM; Ierardi E; Di Leo A; Francavilla A
Virchows Arch; 2004 Jun; 444(6):554-60. PubMed ID: 15071740
[TBL] [Abstract][Full Text] [Related]
2. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies.
Barone M; Francavilla A; Polimeno L; Ierardi E; Romanelli D; Berloco P; Di Leo A; Panella C
Hepatology; 1996 May; 23(5):1159-66. PubMed ID: 8621149
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholate alleviates alcoholic fatty liver damage in rats.
Oliva L; Beaugé F; Choquart D; Montet AM; Guitaoui M; Montet JC
Alcohol Clin Exp Res; 1998 Oct; 22(7):1538-43. PubMed ID: 9802540
[TBL] [Abstract][Full Text] [Related]
4. Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice.
Barone M; Maiorano E; Ladisa R; Cuomo R; Pece A; Berloco P; Caruso ML; Valentini AM; Iolascon A; Francavilla A; Di Leo A; Ierardi E
Hepatology; 2003 Apr; 37(4):880-6. PubMed ID: 12668981
[TBL] [Abstract][Full Text] [Related]
5. Taurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expression.
Mancinelli R; Onori P; Gaudio E; Franchitto A; Carpino G; Ueno Y; Alvaro D; Annarale LP; Demorrow S; Francis H
Exp Biol Med (Maywood); 2009 Apr; 234(4):462-74. PubMed ID: 19234059
[TBL] [Abstract][Full Text] [Related]
6. Studies in vitro on the influence of ursodeoxycholate sodium salt (UDC) on hepatocyte proliferation.
Barone M; Panella C; Angelini A; Romanelli D; Francavilla A
J Surg Oncol Suppl; 1993; 3():8-13. PubMed ID: 8503985
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha.
Alpini G; Baiocchi L; Glaser S; Ueno Y; Marzioni M; Francis H; Phinizy JL; Angelico M; Lesage G
Hepatology; 2002 May; 35(5):1041-52. PubMed ID: 11981754
[TBL] [Abstract][Full Text] [Related]
8. Taurocholic acid prevents biliary damage induced by hepatic artery ligation in cholestatic rats.
Glaser S; Onori P; Gaudio E; Ueno Y; Pannarale L; Franchitto A; Francis H; Mancinelli R; Carpino G; Venter J; White M; Kopriva S; Vetuschi A; Sferra R; Alpini G
Dig Liver Dis; 2010 Oct; 42(10):709-17. PubMed ID: 20303838
[TBL] [Abstract][Full Text] [Related]
9. Effects of secretin on bile production in two kinds of cholestatic models by choledocho-caval fistula and bile duct ligation in rats.
Fukumoto Y; Ando M; Yasunaga M; Okuda M; Okita K
Gastroenterol Jpn; 1992 Jun; 27(3):396-404. PubMed ID: 1624081
[TBL] [Abstract][Full Text] [Related]
10. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat.
Frezza EE; Gerunda GE; Plebani M; Galligioni A; Giacomini A; Neri D; Faccioli AM; Tiribelli C
Dig Dis Sci; 1993 Jul; 38(7):1291-6. PubMed ID: 8325189
[TBL] [Abstract][Full Text] [Related]
11. The effect of ursodeoxycholic acid on oxidative stress level and DNase activity in rat liver after bile duct ligation.
Sokolovic D; Nikolic J; Kocic G; Jevtovic-Stoimenov T; Veljkovic A; Stojanovic M; Stanojkovic Z; Sokolovic DM; Jelic M
Drug Chem Toxicol; 2013 Apr; 36(2):141-8. PubMed ID: 22385135
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
[TBL] [Abstract][Full Text] [Related]
13. Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.
Marzioni M; Francis H; Benedetti A; Ueno Y; Fava G; Venter J; Reichenbach R; Mancino MG; Summers R; Alpini G; Glaser S
Am J Pathol; 2006 Feb; 168(2):398-409. PubMed ID: 16436655
[TBL] [Abstract][Full Text] [Related]
14. Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats.
Gaudio E; Barbaro B; Alvaro D; Glaser S; Francis H; Franchitto A; Onori P; Ueno Y; Marzioni M; Fava G; Venter J; Reichenbach R; Summers R; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G307-17. PubMed ID: 16574985
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis.
Sánchez Pozzi EJ; Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Rodríguez Garay EA; Mottino AD
J Pharmacol Exp Ther; 2003 Jul; 306(1):279-86. PubMed ID: 12663690
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Weiglein AH; Lammert F; Marschall HU; Tsybrovskyy O; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2002 Oct; 123(4):1238-51. PubMed ID: 12360485
[TBL] [Abstract][Full Text] [Related]
18. Effect of intraduodenal administration of ursodeoxycholic acid on interdigestive interaction between gallbladder motility, pancreatic secretion and endocrine activity.
Neubrand MW; Dominguez-Munoz JE; Reichel C; Kampmann S; Eschmann K; von Falkenhausen M; Bregulla M; Malfertheiner P; Sauerbruch T
Digestion; 2004; 69(3):149-57. PubMed ID: 15114045
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
Purucker E; Marschall HU; Winograd R; Matern S
Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
